Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PMN.TO Relative to the S&P 500

PMN.TO Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the ProMIS Neurosciences Inc. (TSE:PMN.TO) seasonal charts above shows that a Buy Date of December 6 and a Sell Date of March 7 has resulted in a geometric average return of 13.77% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 30.42% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson’s disease, and dementia with Lewy bodies. It primarily operates in Canada.

To download PMN.TO seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PMN.TO